LyndaE(Oien)PolgreenMDMS

PubMed

• 1 citations
  Autosomal Dominant Osteopetrosis (ADO) caused by a Missense Variant in the TCIRG1 Gene.
  Katz, A., Hart, M., Warden, S., Alam, I., Imel, E., Jodeh, W., Niziolek, P., Ing, S., Polgreen, L., Econs, M.> ;The Journal of Clinical Endocrinology and Metabolism. 2024 Jan 23
• What is the Role for Pediatric Endocrinologists in the Management of Skeletal Dysplasias?
  Rosenfeld, R., Merchant, N., Polgreen, L.> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Dec 11
• 2 citations
  Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.
  Ravi Savarirayan, William R Wilcox, Paul Harmatz, John Phillips 3rd, Lynda E Polgreen, Louise Tofts, Keiichi Ozono, Paul Arundel, Melita Irving, Carlos A Bacino, Donal...> ;The Lancet. Child & Adolescent Health. 2024 Jan 1
• Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scores.
  Vaiva Deltuvaite-Thomas, Mickaël De Backer, Samantha Parker, Marie Deneux, Lynda E Polgreen, Cara O'Neill, Samuel Salvaggio, Marc Buyse> ;Orphanet Journal of Rare Diseases. 2023 Oct 12
• Hurler Syndrome Glycosaminoglycans Decrease in Cerebrospinal Fluid without Brain-Targeted Therapy.
  Troy C Lund, Elizabeth Braunlin, Lynda E Polgreen, Ashish O Gupta, Paul J Orchard, Julie B Eisengart> ;Annals of Neurology. 2023 Dec 1
• Autosomal dominant osteopetrosis.
  Lynda E Polgreen, Erik A Imel, Michael J Econs> ;Bone. 2023 May 1
• 1 citations
  Persistent bone and joint disease despite current treatments for mucopolysaccharidosis types I, II, and VI: Data from a 10-year prospective study.
  Bradley S Miller, Ellen B Fung, Klane K White, Troy C Lund, Paul Harmatz, Paul J Orchard, Chester B Whitley, Lynda E Polgreen> ;Journal of Inherited Metabolic Disease. 2023 Jul 1
• 4 citations
  Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study.
  Ravi Savarirayan, Melita Irving, Paul Harmatz, Borja Delgado, William R Wilcox, John Philips, Natalie Owen, Carlos A Bacino, Louise Tofts, Joel Charrow, Lynda E Polgre...> ;Genetics in Medicine. 2022 Dec 1
• 1 citations
  Growth in individuals with attenuated mucopolysaccharidosis type I during untreated and treated periods: Data from the MPS I registry.
  Lynda E Polgreen, Luisa Bay, Lorne A Clarke, Nathalie Guffon, Simon A Jones, Joseph Muenzer, Ana Lorena Flores, Kathryn Wilson, David Viskochil> ;American Journal of Medical Genetics. Part A. 2022 Oct 1
• Unusual Cortical Phenotype After Hematopoietic Stem Cell Transplantation in a Patient With Osteopetrosis.
  Sonia Afshariyamchlou, Michelle Ng, Asmaa Ferdjallah, Stuart J Warden, Paul Niziolek, Imranul Alam, Lynda E Polgreen, Erik A Imel, Paul Orchard, Michael J Econs> ;JBMR Plus. 2022 Jun 1
• 4 citations
  Hematopoietic stem cell transplant for Hurler syndrome: does using bone marrow or umbilical cord blood make a difference?
  Paul J Orchard, Ashish O Gupta, Julie B Eisengart, Lynda E Polgreen, Laura M Pollard, Elizabeth Braunlin, Marzia Pasquali, Troy C Lund> ;Blood Advances. 2022 Dec 13
• 5 citations
  Open-Label Pilot Study of Interferon Gamma-1b in Patients With Non-Infantile Osteopetrosis.
  Andrew Nguyen, Weston P Miller, Ashish Gupta, Troy C Lund, Daniel Schiferl, Lok Sze Kelvin Lam, Zorayr Arzumanyan, Paul J Orchard, Lynda E Polgreen> ;JBMR Plus. 2022 Mar 1
• 28 citations
  Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study
  Ravi Savarirayan, Louise Tofts, Melita Irving, William R. Wilcox, Carlos A. Bacino, Julie Hoover-Fong, Rosendo Ullot Font, Paul Harmatz, Frank Rutsch, Michael B. Bober...> ;Genetics in Medicine. 2021 Aug 2
• 10 citations
  Biomarkers for prediction of skeletal disease progression in mucopolysaccharidosis type I.
  Troy C. Lund, Terence M. Doherty, Julie B. Eisengart, Rebecca Freese, Kyle Rudser, Ellen B. Fung, Bradley S. Miller, Klane K. White, Paul J. Orchard, Chester B. Whitle...> ;JIMD Reports. 2021 Mar 1
• 4 citations
  Hepatic Steatosis is Negatively Associated with Bone Mineral Density in Children.
  Lauren F. Chun, Elizabeth L. Yu, Mary Catherine Sawh, Craig Bross, Jeanne F. Nichols, Lynda E. Polgreen, Cynthia Knott, Alexandra Schlein, Claude B. Sirlin, Michael S....> ;The Journal of Pediatrics. 2021 Feb 2
• 29 citations
  Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement.
  Christiane S. Hampe, Jacob Wesley, Troy C. Lund, Paul J. Orchard, Lynda E. Polgreen, Julie B. Eisengart, Linda K. McLoon, Sebahattin Cureoglu, Patricia A. Schachern, R...> ;Biomolecules. 2021 Jan 29
• 65 citations
  Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial
  Ravi Savarirayan, Louise Tofts, Melita Irving, William R. Wilcox, Carlos A. Bacino, Julie Hoover-Fong, Rosendo Ullot Font, Paul Harmatz, Frank Rutsch, Michael B. Bober...> ;Lancet. 2020 Sep 5
• 1 citations
  Dysostosis Multiplex in Human Mucopolysaccharidosis Type 1 H and in Animal Models of the Disease.
  Christiane S. Hampe, Lynda E. Polgreen, Troy C. Lund, R. Scott McIvor> ;Pediatric Endocrinology Reviews. 2020 Aug 1
• 14 citations
  Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot study.
  Agnes Chen, Paul Harmatz, Igor Nestrasil, Julie B. Eisengart, Kelly King, Kyle Rudser, Alexander M. Kaizer, Alena Svátková, Amy Wakumoto, Steven Q. Le, Jacqueline Madd...> ;Molecular Genetics and Metabolism. 2020 Feb 1
• 9 citations
  Early characteristics of bone deficits in children with Fontan palliation.
  Kyriakie Sarafoglou, Anna Petryk, Pooja E. Mishra, Lynda E. Polgreen, Angela Panoskaltsis-Mortari, Roland Brown, Bradley S. Marino, David B. Gremmels, Charles W. Shepa...> ;Cardiology in the Young. 2020 Jan 1
• 9 citations
  Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation.
  Lynda E. Polgreen, Troy C. Lund, Elizabeth A. Braunlin, Jakub Tolar, Bradley S. Miller, Ellen B. Fung, Chester B. Whitley, Julie B. Eisengart, Elise F. Northrop, Kyle ...> ;Pediatric Research. 2020 Jan 1
• 22 citations
  Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes
  Julie B. Eisengart, Elizabeth I. Pierpont, Alexander M. Kaizer, Kyle Rudser, Kelly King, Marzia Pasquali, Lynda E. Polgreen, Patricia I. Dickson, Steven Q. Le, Weston ...> ;Genetics in Medicine. 2019 Nov 1
• 4 citations
  Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysacchar...
  Moin Vera, Steven Q. Le, Alla Victoroff, Merry Passage, Jillian R. Brown, Brett E. Crawford, Lynda E. Polgreen, Agnes Chen, Patricia I. Dickson> ;Molecular Genetics and Metabolism. 2020 Feb 1
• 6 citations
  Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes
  Troy C. Lund, Weston P. Miller, Ai Yin Liao, Jakub Tolar, Ryan Shanley, Marzia Pasquali, Nicole Sando, Brian W. Bigger, Lynda E. Polgreen, Paul J. Orchard> ;Scientific Reports. 2019 Oct 1
• 8 citations
  Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights.
  Ana Maria Martins, Kristin Lindstrom, Sandra Obikawa Kyosen, Maria Veronica Munoz-Rojas, Nathan Thibault, Lynda E. Polgreen> ;BMC Endocrine Disorders. 2018 Nov 12
• Join now to see all